Tuesday, September 26, 2017

Pharma Reviews: CVC Is Said to Mull Options for $4 Billion Drugmaker Alvogen

(Bloomberg) -- Alvogen's private equity owners including CVC Capital Partners are exploring options for the generic pharmaceutical company, which ...
Read more: CVC Is Said to Mull Options for $4 Billion Drugmaker Alvogen